Skip to main content

Table 3 Amyloid imaging and prediction of conversion to Alzheimer's disease

From: Amyloid imaging and memory change for prediction of cognitive impairment

Study

Year

Radiotracer

Samplea

Number of subjectsa

Mean age (SD)

Method

Findings

Okello et al. [24]

2009

PiB

MCI

31

69.4

(7.9)

SUVR

82% PiB-positive MCI convert to AD compared to 7% of PiB-negative MCI

47% PiB-positive MCI who convert to AD within 1 year have higher PiB in anterior cingulate and frontal cortex (P < 0.05), APOE ε4 is associated with faster conversion rates in PiB-positive MCI (P < 0.05)

Wolk et al. [25]

2009

PiB

MCI

26 (23 with follow-up)

70.2

(8.8)

DVR

38% PiB-positive MCI but no PiB- convert to AD over 22 months

Morris et al. [45]

2009

PiB

CN

159

71.5

(8.6)

BP

Higher PiB retention predicts progression from CDR 0 to MCI (hazard ratio = 2.74) and AD (hazard ratio = 4.85) over mean 2.4 years

Koivunen et al. [44]

2008

PiB

aMCI

15

71.1

(7.2)

SUVR,

DVR

Elevated PiB in six converters in posterior cingulate and frontal cortex as well as elevated neocortical score

Forsberg et al. [23]

2008

PiB

MCI

21

63.3

(7.8)

SUVR

Higher PiB retention in frontal, parietal, and temporal cortices (P < 0.01) in MCI converters than CN individuals Higher PiB retention in posterior cingulate gyrus in MCI converters than MCI nonconverters (P < 0.01) No difference in PiB retention between MCI converters and AD

Small et al. [20]

2006

[18F]FDDNP

AD, MCI, CN

4 MCI,

8 CN

NA for this

subset

DVR

Three disease progressors had increases in [18F]FDDNP between 5.5% to 11.2% compared to ≤3% in nine non-progressors

  1. aIn some cases a study subsample. AD, Alzheimer's disease; aMCI, amnestic MCI; APOE, Apolipoprotein E; BP, binding potential; CN, cognitively normal; DVR, distribution volume ratio; MCI, mild cognitive impairment; NA, not available; PiB, [11C]Pittsburgh Compound-B; SD, standard deviation; SUVR, standard uptake value ratio.